Comparing GLP-1 Receptor Agonists with Other Diabetes Treatments When considering treatment options for type 2 diabetes, GLP-1 receptor agonists offer distinct advantages compared with other glucose-lowering therapies, though the optimal choice depends on individual patient characteristics, preferences, and clinical circumstances
Semaglutide GLP-1 lowers levels of systolic and diastolic blood pressure, improving heart health, which can lend itself to improved weight loss results
Maya Bunik, a Colorado pediatrician and chair of the American Academy of Pediatrics section on breastfeeding, in her book about the practice
(Lausanne) 10 , 155 (2019)
This study further demonstrated that exendin-4 treatment additionally reduced the presence of key inflammatory molecules, including TNF-alpha, interleukin 1 beta (IL-1beta), and IL-6, in mice livers [46], providing evidence for potential GLP-1 treatment for inflammation related to steatohepatitis
However, many of these findings come from preclinical studies, with human evidence still developing